Recently Viewed
Clear All₹4,220.00
₹-59.40
(-1.39%)
As on 19-Mar-2026 14:44IST
Today’s Range
52 Week Range
Liquidity
Market cap
₹9,823 Cr
Revenue (TTM)
₹878 Cr
Net Profit (TTM)
₹240 Cr
ROE
79.3 %
ROCE
104.3 %
P/E Ratio
40.9
P/B Ratio
25.6
Industry P/E
--
EV/EBITDA
28.9
Div. Yield
1.8 %
Debt to Equity
0
Book Value
₹166.7
EPS
₹102
Face value
10
Shares outstanding
23,030,622
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sanofi Consumer Healthcare India
| -6.6 | 3.3 | -8.7 | -12.1 | -- | -- | -- |
|
BSE Healthcare
| -4.0 | -3.7 | -4.0 | 3.1 | 24.7 | 15.5 | 10.6 |
|
Company
|
2025
|
|---|---|
|
Sanofi Consumer Healthcare India
| -7.9 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sanofi Consumer Healthcare India
|
4,220.0 | 9,822.6 | 878.4 | 240.1 | 33.8 | 73.3 | 40.9 | 25.6 |
| 162.5 | 2,616.7 | 2,796.8 | 118.8 | 8.1 | 2.3 | 22 | 0.4 | |
| 144.1 | 644.8 | 326.7 | 46.5 | -- | 30.5 | 13.9 | 1.5 | |
| 449.8 | 10,795.2 | 3,262.7 | 439.0 | 15.3 | 16 | 24.6 | 3.6 | |
| 53.3 | 189.9 | 133.8 | -0.3 | -0.7 | -0.6 | -- | 1.9 | |
| 162.4 | 7,474.9 | 2,803.3 | 361.8 | 15.5 | 14 | 20.7 | 2.7 | |
| 21.3 | 648.3 | 1,450.4 | 47.9 | 6.6 | 10.1 | 14.5 | 1.4 | |
| 1,008.5 | 21,433.1 | 2,169.9 | 332.9 | 20.9 | 15.4 | 64.4 | 9.0 | |
| 38.1 | 564.1 | 0.0 | 1.6 | -- | -0.5 | 350.6 | 21.0 | |
| 24.8 | 54.7 | 51.4 | 4.5 | 22.0 | 5.2 | 12.1 | 0.6 |
No Review & Analysis are available.
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and... Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Sanofi India Limited. Read more
Incorporated
2023
Chairman
Amit Jain
Managing Director
Himanshu Bakshi
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Sanofi Consumer Healthcare India Ltd is ₹4,220.00 (NSE) and ₹4,227.20 (BSE) as of 19-Mar-2026 14:44 IST. Sanofi Consumer Healthcare India Ltd has given a return of -12.1% in the last 1 years.
The P/E ratio of Sanofi Consumer Healthcare India Ltd is 40.91 times as on 19-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
62.61
|
41.66
|
|
2023
|
0.00
|
0.00
|
|
2024
|
62.61
|
41.66
|
|
2023
|
0.00
|
0.00
|
The 52-week high and low of Sanofi Consumer Healthcare India Ltd are Rs 5,894.50 and Rs 3,975.00 as of 19-Mar-2026.
Sanofi Consumer Healthcare India Ltd has a market capitalisation of ₹ 9,823 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Sanofi Consumer Healthcare India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.